A Study of Aripiprazole in the Management of Patients With Schizophrenia in the General Psychiatric Practices

PHASE3CompletedINTERVENTIONAL
Enrollment

1,200

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Schizophrenia
Interventions
DRUG

Aripiprazole

Trial Locations (20)

Unknown

Local Institution, Antwerp

Local Institution, Brussels

Local Institution, Diest

Local Institution, Kortenberg

Local Institution, Liège

Local Institution, Sint-Michiels

Local Institution, Sint-Niklaas

Local Institution, Sint-Truiden

Local Institution, Tournai

Local Institution, Rennes

Local Institution, Amersfoort

Local Institution, Raalte

Local Institution, Rotterdam

Local Institution, Barcelos

Local Institution, Ceira

Local Institution, Coimbra

Local Institution, Lisbon

Local Institution, Barcelona

Local Institution, Salamanca

Local Institution, Seville

Sponsors
All Listed Sponsors
collaborator

Otsuka America Pharmaceutical

INDUSTRY

lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY

NCT00237939 - A Study of Aripiprazole in the Management of Patients With Schizophrenia in the General Psychiatric Practices | Biotech Hunter | Biotech Hunter